TMCnet News
OptraSCAN® & Neuberg Diagnostics Announce the Launch of Global TELEPath™ Network in UAE, India and South Africa Through PartnershipOptraSCAN® Inc., global digital pathology solutions provider, and Neuberg Diagnostics, one of the Top 4 Diagnostics Service Provider in India, today announced the launch of Global TELEPath™ Network for the pathologist community in UAE, India and South Africa under a new partnership namely, "Neuberg DIGIPATH, Powered by OptraSCAN® Inc." at Medlab 2019, Dubai. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190205005349/en/ 
OptraSCAN and Neuberg Diagnostics offering Global TELEPath Network (Graphic: Business Wire) "This collaboration is the next step forward in a healthcare eco-system that combines the advanced digital pathology capabilities offered by OptraSCAN® and the exceptional histopathology and cytology services provided by Neuberg Diagnostics to provide advanced and affordable digital pathology products in India, Middle East, Africa and beyond," said Abhi Gholap, Founder & CEO, OptraSCAN. "OptraSCAN's Global TELEPath™ Network has great market traction in USA and European region, so this alliance is also a part of our global strategy to create innovative healthcare affiliations with leading healthcare providers around the globe to enhance our reach in untapped regions." This new partnership brings to the table a whole new array of services related to digitization of tissue slides and telepathology with an objective of making new-age life-saving healthcare technology available to the human kind. The partnership promises access to a large pool of histopathologists from UAE, India and South Africa. Histopathology is, among other applications, integral to cancer management throuh the staging and grading of tumours. The partners intend to provide labs with cutting-edge technology using the following products and services:
"With OptraSCAN's expertise in providing new-age technology that are well-equipped with AI & ML based analysis tools, the newly combined collaboration will enable us to expand the service as well as the geographic reach of Neuberg's existing lab services. We expect the economies of scale from this partnership to help us bring better value to our clients and expand our service offerings," said Dr. GSK Velu, Founder & Chairman, Neuberg Diagnostics. Through this partnership, both the companies aim to expand their market base and have planned a phase and region-wise expansion. They intend to make on-demand cutting-edge digital pathology solutions available to leading hospitals in the Middle East region thus taking healthcare and diagnostics deep into the digital age. About OptraSCAN, Inc. An ISO 13485 certified company and CE marked whole slide scanners for IVD use, OptraSCAN® has developed world's first 'On-Demand Digital Pathology' System; focused on delivering fully integrated, affordable systems & solutions. These serve as the perfect tool for transition from conventional microscopy to Digital Pathology for the effective acquisition of whole slide images, viewing, storing, real time sharing, and reporting via On-Demand or outright purchase model. Follow Us on LinkedIn and Twitter. About Neuberg Diagnostics When three large medical laboratory chains of repute in India, one in South Africa and one in the United Arab Emirates decided to come together under one organization and pool their combined history of 200 years and their annual experience of dealing with 20 million medical samples annually, the Neuberg Diagnostics was born in October 2017. Within one year of its inception Neuberg has become one of the Top 4 Diagnostics companies of Indian Origin with comprehensive presence across India, UAE and South Africa. The network is now being expanded to other parts of Middle East / Africa along with upcoming laboratories in USA/ Europe too.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190205005349/en/ |
